NEPHROS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NEPHROS, INC. stock issued during period, value, new issues for the quarter ending 2021-09-30 was $1.12M.
- NEPHROS, INC. stock issued during period, value, new issues for the quarter ending 2020-03-31 was $6.77M.
- NEPHROS, INC. stock issued during period, value, new issues for the quarter ending 2019-06-30 was $1.99M, a 31.87% decline year-over-year.
- NEPHROS, INC. stock issued during period, value, new issues for the quarter ending 2018-06-30 was $2.92M.
- NEPHROS, INC. stock issued during period, value, new issues for fiscal 2020 was $11.45M, a 474.90% increase from fiscal 2019.
- NEPHROS, INC. stock issued during period, value, new issues for fiscal 2019 was $1.99M, a 47.27% decline from fiscal 2018.
- NEPHROS, INC. stock issued during period, value, new issues for fiscal 2018 was $3.78M, a 254.41% increase from fiscal 2017.
- NEPHROS, INC. stock issued during period, value, new issues for fiscal 2017 was $1.07M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2021-09-30 | $1.12M 10-Q · filed 2021-11-04 | |
| 2020-12-31 | $11.45M 10-K · filed 2022-03-03 | |
| 2020-03-31 | $6.77M 10-Q · filed 2021-11-04 | |
| 2019-12-31 | $1.99M 10-K · filed 2021-03-01 | |
| 2019-06-30 | $1.99M 10-Q · filed 2020-11-05 | |
| 2018-12-31 | $3.78M 10-K · filed 2020-02-27 | |
| 2018-06-30 | $2.92M 10-Q · filed 2019-11-06 | $3.78M derived: sum of 4 quarters · filed 2019-11-06 |
| 2018-03-31 | $854.00K 10-Q · filed 2019-11-06 | $846.00K derived: sum of 4 quarters · filed 2019-11-06 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.07M 10-K · filed 2018-02-26 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | |
| 2017-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | |
| 2017-03-31 | $1.07M 10-Q · filed 2017-05-09 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |